Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer

Escudero-Esparza, Astrid, Bartoschek, Michael, Gialeli, Chrysostomi, Okroj, Marcin, Owen, Sioned, Jirström, Karin, Orimo, Akira, Jiang, Wen G. ORCID: https://orcid.org/0000-0002-3283-1111, Pietras, Kristian and Blom, Anna M. 2023. Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer. Oncotarget 14 (1) , pp. 481-482. 10.18632/oncotarget.28426

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (590kB) | Preview

Abstract

This article has been corrected: In Figure 4B, the image of MDA-MB-231 cells expressing CSMD1 is an accidental duplicate of the image showing invaded BT-20 cells expressing CSMD1 in Figure 4A. The correct Figure 4, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper. Original article: Oncotarget. 2016; 7:76920–76933. https://doi.org/10.18632/oncotarget.12729

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Additional Information:	This record is a correction to -http://dx.doi.org/10.18632/oncotarget.12729 https://orca.cardiff.ac.uk/id/eprint/95525/
Publisher:	Impact Journals
ISSN:	1949-2553
Date of First Compliant Deposit:	30 June 2023
Date of Acceptance:	19 May 2023
Last Modified:	06 Jul 2023 07:02
URI:	https://orca.cardiff.ac.uk/id/eprint/160750

Actions (repository staff only)

Edit Item